Informationen:
Fehler:
ID
37235
Beschreibung
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02400060
Link
https://clinicaltrials.gov/show/NCT02400060
Stichworte
Versionen (1)
- 10.07.19 10.07.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
10. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Stage IA Breast Cancer NCT02400060
Eligibility Stage IA Breast Cancer NCT02400060
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Stage IA Breast Cancer NCT02400060
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender
Item
eligible women are those who:
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
are post-menopausal, verified by:
boolean
C0232970 (UMLS CUI [1])
Status post Bilateral oophorectomy
Item
post bilateral surgical oophorectomy; or
boolean
C0231290 (UMLS CUI [1,1])
C0278321 (UMLS CUI [1,2])
C0278321 (UMLS CUI [1,2])
Menstruation absent Duration
Item
no spontaneous menses >= 1 year; or
boolean
C0497456 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Menstruation absent Duration | Follicle stimulating hormone measurement Postmenopausal state | Estradiol measurement Postmenopausal state
Item
no menses for < 1 year with follicle stimulating hormone (fsh) and estradiol levels in postmenopausal range, according to institutional standards
boolean
C0497456 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0202022 (UMLS CUI [2,1])
C0232970 (UMLS CUI [2,2])
C0337434 (UMLS CUI [3,1])
C0232970 (UMLS CUI [3,2])
C0449238 (UMLS CUI [1,2])
C0202022 (UMLS CUI [2,1])
C0232970 (UMLS CUI [2,2])
C0337434 (UMLS CUI [3,1])
C0232970 (UMLS CUI [3,2])
Breast Carcinoma Primary TNM Breast tumor staging
Item
are diagnosed with primary breast cancer (bc) (stages i-iii)
boolean
C0678222 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
C0205225 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
Hormone Therapy Adjuvant | Tamoxifen | Aromatase Inhibitors
Item
eligible to receive aht (tamoxifen or an aromatase inhibitors [ai]) for the first time
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
C0593802 (UMLS CUI [3])
C1522673 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
C0593802 (UMLS CUI [3])
First line treatment Completed
Item
completed all primary treatment
boolean
C1708063 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])
Availability of Smartphone
Item
own a smartphone (in order to receive text messages and utilize the phone app)
boolean
C0470187 (UMLS CUI [1,1])
C3204335 (UMLS CUI [1,2])
C3204335 (UMLS CUI [1,2])
Receive Text Messages Smartphone
Item
agree to receive text messages on their smartphone over a 3-month period
boolean
C1514756 (UMLS CUI [1,1])
C3178910 (UMLS CUI [1,2])
C3204335 (UMLS CUI [1,3])
C3178910 (UMLS CUI [1,2])
C3204335 (UMLS CUI [1,3])
Informed Consent | With permission for Review of Medical Records
Item
provide consent and permission to review their medical records
boolean
C0021430 (UMLS CUI [1])
C0521105 (UMLS CUI [2,1])
C0699752 (UMLS CUI [2,2])
C0025102 (UMLS CUI [2,3])
C0521105 (UMLS CUI [2,1])
C0699752 (UMLS CUI [2,2])
C0025102 (UMLS CUI [2,3])
Reside Study Site Area
Item
plan to stay in the study area for 3 months
boolean
C2982691 (UMLS CUI [1,1])
C2825164 (UMLS CUI [1,2])
C0017446 (UMLS CUI [1,3])
C2825164 (UMLS CUI [1,2])
C0017446 (UMLS CUI [1,3])